Hyponatraemia during terlipressin therapy. 2010

Aleksander Krag, and Lise Hobolth, and Søren Møller, and Flemming Bendtsen

UI MeSH Term Description Entries
D007010 Hyponatremia Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed) Hyponatremias
D008236 Lypressin The porcine antidiuretic hormone (VASOPRESSINS). It is a cyclic nonapeptide that differs from ARG-VASOPRESSIN by one amino acid, containing a LYSINE at residue 8 instead of an ARGININE. Lys-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Lysine Vasopressin,Vasopressin, Lysine,8-Lysine Vasopressin,Diapid,Lys-Vasopressin,Lysyl Vasopressin,Postacton,8 Lysine Vasopressin,Lys Vasopressin,Vasopressin, 8-Lysine,Vasopressin, Lysyl
D004932 Esophageal and Gastric Varices Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL). Esophageal Varices,Gastric Varices,Esophageal Varix,Gastric Varix,Varices, Esophageal,Varices, Gastric,Varix, Esophageal,Varix, Gastric
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077585 Terlipressin An inactive peptide prodrug that is slowly converted in the body to lypressin. It is used to control bleeding of ESOPHAGEAL VARICES and for the treatment of HEPATORENAL SYNDROME. Glipressin,Gly-Gly-Gly-8-Lys-vasopressin,Glycylpressin,Glypressin,N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin,Remestyp,TGLVP,Terlypressin,Triglycyl Lysine Vasopressin,Triglycyl-(8-lysine)vasopressin,Triglycylvasopressin,Vasopressin, tri-Gly-8-Lys-,Gly Gly Gly 8 Lys vasopressin,tri-Gly-8-Lys- Vasopressin
D014662 Vasoconstrictor Agents Drugs used to cause constriction of the blood vessels. Vasoactive Agonist,Vasoactive Agonists,Vasoconstrictor,Vasoconstrictor Agent,Vasoconstrictor Drug,Vasopressor Agent,Vasopressor Agents,Vasoconstrictor Drugs,Vasoconstrictors,Agent, Vasoconstrictor,Agent, Vasopressor,Agents, Vasoconstrictor,Agents, Vasopressor,Agonist, Vasoactive,Agonists, Vasoactive,Drug, Vasoconstrictor,Drugs, Vasoconstrictor

Related Publications

Aleksander Krag, and Lise Hobolth, and Søren Møller, and Flemming Bendtsen
September 2013, Ugeskrift for laeger,
Aleksander Krag, and Lise Hobolth, and Søren Møller, and Flemming Bendtsen
March 2013, Internal medicine journal,
Aleksander Krag, and Lise Hobolth, and Søren Møller, and Flemming Bendtsen
May 2013, Internal medicine journal,
Aleksander Krag, and Lise Hobolth, and Søren Møller, and Flemming Bendtsen
September 1989, Human toxicology,
Aleksander Krag, and Lise Hobolth, and Søren Møller, and Flemming Bendtsen
December 2015, Journal of clinical pharmacy and therapeutics,
Aleksander Krag, and Lise Hobolth, and Søren Møller, and Flemming Bendtsen
December 2007, Annals of African medicine,
Aleksander Krag, and Lise Hobolth, and Søren Møller, and Flemming Bendtsen
January 2009, BMJ case reports,
Aleksander Krag, and Lise Hobolth, and Søren Møller, and Flemming Bendtsen
May 1983, Neuropediatrics,
Aleksander Krag, and Lise Hobolth, and Søren Møller, and Flemming Bendtsen
December 2019, Journal of clinical pharmacy and therapeutics,
Aleksander Krag, and Lise Hobolth, and Søren Møller, and Flemming Bendtsen
October 1984, Journal of neurology, neurosurgery, and psychiatry,
Copied contents to your clipboard!